| 使用文献 |
使用文献募集中！本製品を使って論文を発表されましたら是非お知らせください。
- Chen XW et al. SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion. Elife. 2, e00444 (2013)(PMID:23580231)
- Carrier B et al. Alpha-lipoic acid reduces LDL-particle number and PCSK9 concentrations in high-fat fed obese Zucker rats. PLoS One. 9, e90863 (2014)(PMID:24595397)
- Sasaki M et al. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways. Arterioscler Thromb Vasc Biol. 34, 1171-8 (2014)(PMID:24675665)
- Galabova G et al. Peptide-based anti-PCSK9 vaccines - an approach for long-term LDLc management. PLoS One. 9, e114469 (2014)(PMID:25474576)
- Berger JM et al. PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension. Atherosclerosis 239, 252-9 (2015)(PMID:25621930)
- Butkinaree C et al. Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other. J Biol Chem. 290, 18609-20 (2015)(PMID:26085104)
- An D et al. Identification of PCSK9 as a novel serum biomarker for the prenatal diagnosis of neural tube defects using iTRAQ quantitative proteomics. Sci Rep. 5, 17559 (2015)(PMID:26691006)
- Haas ME et al. The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia. Circulation 134, 61-72 (2016)(PMID:27358438)
- Ngo Sock ET et al. Combined Effects of Rosuvastatin and Exercise on Gene Expression of Key Molecules Involved in Cholesterol Metabolism in Ovariectomized Rats. PLoS One. 11, e0159550 (2016)(PMID:27442011)
- Lintner NG et al. Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain. PLoS Biol. 15, e2001882 (2017)(PMID:28323820)
- Xu YX et al. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol. Atherosclerosis 268, 196-206 (2018)(PMID:29183623)
- Yang SH et al. Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism. Cardiovasc Diabetol. 17, 48 (2018)(PMID:29618348)
- Ding Z et al. PCSK9 expression in the ischemic heart and its relationship to infarct size, cardiac function and development of autophagy. Cardiovasc Res. (2018) In press.(PMID:29800228)
- Liu Y et al. PCSK9 positively correlates with plasma sdLDL in community-dwelling population but not in diabetic participants after confounder adjustment. Medicine (Baltimore). 98, e15062 (2019)(PMID:30946354)
- Momtazi-Borojeni AA et al. Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer. Arch Med Sci. 15, 559-569 (2019)
(PMID:31110520)
- Momtazi-Borojeni AA et al. Effects of immunization against PCSK9 in an experimental model of breast cancer. Arch Med Sci. 15, 570-579 (2019)
(PMID:31110521)
- Momtazi-Borojeni AA et al. Therapeutic Effect of Nanoliposomal PCSK9 Vaccine in a Mouse Model of Atherosclerosis. BMC Med. 17, 223 (2019)
(PMID:31818299)
- Momtazi-Borojeni AA et al. Effects of Immunisation Against PCSK9 in Mice Bearing Melanoma. Arch Med Sci. 16, 189-199 (2019)(PMID:32051723)
- Low LD et al. IL-13-driven Alterations in Hepatic Cholesterol Handling Contributes to Hypercholesterolemia in a Rat Model of Minimal Change Disease. Clin Sci (Lond). 134, 225-237 (2020)(PMID:31934720)
- Evison BJ et al. A Small Molecule Inhibitor of PCSK9 That Antagonizes LDL Receptor Binding via Interaction With a Cryptic PCSK9 Binding Groove. Bioorg Med Chem. 28, 115344 (2020)(PMID:32051094)
- St-Amand R et al. Two weeks of western diet disrupts liver molecular markers of cholesterol metabolism in rats. Lipids Health Dis. 19, 192 (2020)(PMID:32825820)
- Ding Z et al. NLRP3 inflammasome via IL-1β regulates PCSK9 secretion. Theranostics. 10, 7100-7110 (2020)(PMID:32641981)
|
使用文献
データシート
